| Position | Action |
|---|---|
| New bearish exposure | 1-2% portfolio risk max |
| Tactical short exposure stop placement | $227-230 minimum from $190 entry (2x ATR = $32 stop width) |
HONA at $168 represents a capitulation-driven buying opportunity: a freshly independent aerospace prime with surging aftermarket demand, 12.6% revenue CAGR, strong defense backlog, and 43% drawdown on a temporary supply-chain issue—priced at 17.6x forward PE with asymmetric upside to $220-240 versus limited downside to ~$150.
| Indicator | Value | Signal |
|---|---|---|
| Close | $168.51 | neutral |
| 10 EMA | $193.40 | bearish |
| 50 SMA | $218.96 | bearish |
| 200 SMA | $218.96 | bearish |
| RSI(14) | 35.04 | neutral |
| MACD | -9.41 | bearish |
| MACD Signal | -6.23 | bearish |
| MACD Histogram | -3.19 | bearish |
| Bollinger Upper (20,2σ) | $232.77 | bearish |
| Bollinger Middle (20 SMA) | $202.99 | bearish |
| Bollinger Lower (20,2σ) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Reduce exposure aggressively but do not exit entirely; use defined-risk bearish structures
The asymmetric setup justifies Underweight (not Sell) rating: valuation at 17.6x forward PE is not egregious, the $15.8B debt transformation creates a binary upside catalyst path where an accretive deal announcement could gap the stock $20-30 higher overnight, and this is the first reflexive bounce off a record-volume capitulation bar (not the fourth). Keep rating at Underweight until technical confirmation or catalyst clarity; 25% residual long preserves long-term quality floor while defined-risk put spreads express the bearish view without naked short risk into capitulation squeeze.
When: Announced accretive M&A deal funded by $15.8B debt
Then: Trigger fundamental re-evaluation
↩ rebuts: “Bear treating supply-chain guidance cut as permanent demand impairment”
· concedes: Supply-chain timeline is uncertain; position size should be moderate, not all-in; Morgan Stanley framing is 'fundamentally attractive but execution-constrained,' not an outright bullish call; Technical confirmation (RSI > 50, above 10 EMA) would provide additional entry confidence
HONA at $168 is a trap, not a treat — a freshly levered-up industrial with collapsing margins, negative book equity, execution failure on its debut quarter, and a tape showing lower highs in progress.
· concedes: Supply chain issues are real problems that exist and can theoretically be solved; Aftermarket demand is genuinely strong when supply normalizes; Contrarian sentiment at extremes can mark near-term bottoms; DCF framework is valid if base case assumptions are wrong; Aug 6 may represent near-term capitulation though not a durable bottom
→ vs conservative: Trimming 50-75% and holding the rest is fence-sitting rather than conviction-based risk management
→ vs conservative: Waiting for confirmation means absorbing ~15% additional downside ($25 per share) before acting
→ vs neutral: Acknowledging strong demand doesn't address the supply chain fix timeline or execution uncertainty
→ vs neutral: 17.6x forward PE and 0.92 PEG are meaningless with stale $9.56 EPS estimates that will fall to $5-$6.50
→ vs conservative: RSI above 50 and close above 10 EMA at $193.40 are signals to short, not wait for more confirmation
| $173.21 |
| neutral |
| ATR(14) | 16.42 | neutral |
Support: 154.01 · 150.03 | Resistance: 173.21 · 193.4 · 202.99 · 218.96
HONA is in a confirmed downtrend with all major trend indicators pointing lower. Price is 12.9% below the 10 EMA and 23.1% below both the 50 and 200 SMAs. RSI at 35.04 indicates oversold conditions but lacks confirmation above 50, while MACD at -9.41 with histogram -3.19 shows deteriorating momentum despite the Aug 7 bounce. The Aug 6 capitulation on 20.63M volume (7x average) followed by an 8.03M bounce day represents a classic short-term reversal pattern but does not confirm a durable bottom. The non-confirmed bounce (price up, MACD worse) suggests caution. Trade recommendation is HOLD — existing holders should trim on rallies to $190-$200, new capital should wait for a daily close above the 10 EMA ($193.40) with RSI > 50 or multi-day accumulation signature.
Market Cap
$53.41B
Shares Outstanding
316.88M
Revenue (TTM)
$17.92B
Gross Profit (TTM)
$6.19B
EBITDA (TTM)
$3.54B
Net Income (TTM)
$1.95B
EPS (TTM)
$3.29
Forward EPS
$9.56
PE Ratio (TTM)
51.2x
Forward PE
17.6x
PEG Ratio
0.92
Price/Book
-9.38x
Current Ratio
1.526
Q1 2026 Revenue
$4,352M
Q1 2026 Operating Income
$815M
Q1 2026 Net Income
$504M
Q1 2026 EPS (Diluted)
$1.59
Q1 2026 SG&A Expense
$628M
FY 2025 Total Revenue
$17,404M
FY 2025 Gross Margin
34.8%
FY 2025 Operating Margin
18.7%
FY 2025 Net Income
$1,780M
FY 2025 Diluted EPS
$5.62
FY 2025 FCF
$3.20B
Q1 2026 Total Assets
$21.36B
Q1 2026 Total Debt
$15.85B
Q1 2026 Cash & Equivalents
$1.00B
Q1 2026 Net Debt
$14.85B
Q1 2026 Stockholders Equity
-$3.56B
Q1 2026 Working Capital
$3,588M
Q1 2026 Free Cash Flow
-$362M
52-Week High
$297.50
52-Week Low
$154.01
50/200-Day MA
$222.80
Debt-to-Capital Ratio
~30%
Deferred Revenue
$2.68B
R&D Expense (FY 2025)
$677M
Strengths
Concerns
Honeywell Aerospace presents a mixed fundamental profile with strong top-line growth (12.6% CAGR) offset by significant operational deterioration, including a 35% decline in Q1 2026 net income and 700 bps operating margin compression over two years. The Q1 2026 debt issuance of $15.8B fundamentally transformed the balance sheet, creating negative equity (-$3.6B) and $14.8B net debt, which wipes out traditional safety buffers. The wide valuation gap (51.2x TTM PE vs 17.6x forward PE) creates a binary outcome: the stock is a BUY if $9.56 forward EPS is achievable, but a SELL if earnings recovery disappoints. Given the leverage risk and execution uncertainty, a HOLD stance is recommended pending Q2 2026 margin recovery confirmation and debt purpose disclosure.